UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN C000000008
Receipt No. R000000011
Scientific Title Cyclosporine C2 monitaring for frequently relapsing nephrotic syndrome in children: A randomized controlled trial
Date of disclosure of the study information 2005/08/01
Last modified on 2016/08/19 09:39:11

No. Disposal Last modified on Item of update
1 Insert 2005/06/14 10:31:08
2 Update 2005/06/17 15:54:40 UMIN ID1
3 Update 2005/06/17 15:59:06 UMIN ID1
4 Update 2005/07/11 23:08:29 Date of disclosure of the study information
5 Update 2005/07/22 05:32:39 Key inclusion criteria
Key exclusion criteria
6 Update 2005/07/23 05:11:06 Key inclusion criteria
7 Update 2005/07/23 05:17:08 Key exclusion criteria
8 Update 2005/07/23 05:30:28 Acronym
Acronym
9 Update 2005/07/23 05:31:10 Condition
Condition
10 Update 2005/07/23 05:31:47 Institute
11 Update 2005/07/23 05:48:09 Key exclusion criteria
12 Update 2005/07/23 06:11:58 Organization
Organization
Division name
Division name
13 Update 2005/08/11 00:56:25 Acronym
Acronym
14 Update 2005/08/28 04:09:47 Organization1
15 Update 2006/01/26 07:59:46 Blinding
16 Update 2009/08/11 11:59:44 Recruitment status
17 Update 2011/07/01 19:04:27 UMIN ID1
18 Update 2011/07/04 10:36:19 Organization
Organization
Division name
Division name
Address
Address
Name of person sending information
Organization
Division name
Address
Post marketing survey by drug manufacture etc., specified by Japanese law.
19 Update 2013/12/25 09:49:48 TEL
Email
Last name of contact person
Last name of contact person
Address
TEL
Email
Name of person sending information
Name of person sending information
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
20 Update 2013/12/25 09:53:39 Recruitment status
Publication of results
21 Update 2016/08/19 09:38:20 Randomization unit
Key inclusion criteria
Key exclusion criteria
22 Update 2016/08/19 09:39:11 Name of primary sponsor
Organization
Category of Funding Organization


Contact us.